171 related articles for article (PubMed ID: 24590773)
61. Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.
Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; Rai SN; Riley EC; Hines LM; Giuliano AR; John EM; Stern MC; Torres-Mejía G; Wolff RK; Slattery ML
Cancer Causes Control; 2014 Nov; 25(11):1461-71. PubMed ID: 25088806
[TBL] [Abstract][Full Text] [Related]
62. Association of Single Nucleotide Polymorphisms in the CYP19A1 Gene with Female Pattern Hair Loss in a Chinese Population.
Rui W; Sheng Y; Hu R; Miao Y; Han Y; Guo X; Qi S; Xu F; Xu J; Yang Q
Dermatology; 2015; 231(3):239-44. PubMed ID: 26228318
[TBL] [Abstract][Full Text] [Related]
63. Significance of the Estrogen Hormone and Single Nucleotide Polymorphisms in the Progression of Breast Cancer among Female.
Mohammed Alwan A; Tavakol Afshari J; Afzaljavan F
Arch Razi Inst; 2022 Jun; 77(3):943-958. PubMed ID: 36618302
[TBL] [Abstract][Full Text] [Related]
64. Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.
Hosono S; Matsuo K; Ito H; Watanabe M; Hirose K; Nakanishi T; Tajima K; Tanaka H
Asian Pac J Cancer Prev; 2011; 12(10):2747-52. PubMed ID: 22320986
[TBL] [Abstract][Full Text] [Related]
65. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D
Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132
[TBL] [Abstract][Full Text] [Related]
66. The
Lv F; Huang W; Wang Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):486-495. PubMed ID: 34280004
[No Abstract] [Full Text] [Related]
67. CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy.
Mazzuca F; Botticelli A; Mazzotti E; La Torre M; Borro M; Marchetti L; Maddalena C; Gentile G; Simmaco M; Marchetti P
Eurasian J Med; 2016 Feb; 48(1):10-4. PubMed ID: 27026757
[TBL] [Abstract][Full Text] [Related]
68. Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer.
Dempsey JM; Xi J; Henry NL; Rae JM; Hertz DL
Physiol Genomics; 2018 Feb; 50(2):98-99. PubMed ID: 29212847
[TBL] [Abstract][Full Text] [Related]
69. Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy.
Ingle JN; Xie F; Ellis MJ; Goss PE; Shepherd LE; Chapman JW; Chen BE; Kubo M; Furukawa Y; Momozawa Y; Stearns V; Pritchard KI; Barman P; Carlson EE; Goetz MP; Weinshilboum RM; Kalari KR; Wang L
Cancer Res; 2016 Dec; 76(23):7012-7023. PubMed ID: 27758888
[TBL] [Abstract][Full Text] [Related]
70. Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
Ingle JN; Kalari KR; Momozawa Y; Kubo M; Furukawa Y; Shepherd LE; Ellis MJ; Goss PE; Barman P; Carlson EE; Sinnwell JP; Tang X; Goetz MP; Chen BE; Cairns J; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2019 Oct; 29(8):183-191. PubMed ID: 31211741
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer Cases.
Tüzüner MB; Öztürk T; Eronat AP; Seyhan F; Kısakesen Hİ; Calay Z; İlvan Ş; Turna H; Yılmaz-Aydoğan H; Bermek H; Öztürk O
Biochem Genet; 2016 Dec; 54(6):784-802. PubMed ID: 27365044
[TBL] [Abstract][Full Text] [Related]
72. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.
Goodman MT; Lurie G; Thompson PJ; McDuffie KE; Carney ME
Endocr Relat Cancer; 2008 Dec; 15(4):1055-60. PubMed ID: 18667686
[TBL] [Abstract][Full Text] [Related]
73. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants.
Ramirez-Lorca R; Grilo A; Martinez-Larrad MT; Manzano L; Serrano-Hernando FJ; Moron FJ; Perez-Gonzalez V; Gonzalez-Sanchez JL; Fresneda J; Fernandez-Parrilla R; Moñux G; Molero E; Sanchez E; Martinez-Calatrava MJ; Saban-Ruiz J; Ruiz A; Saez ME; Serrano-Rios M
Hypertension; 2007 Nov; 50(5):884-90. PubMed ID: 17893373
[TBL] [Abstract][Full Text] [Related]
74. Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.
Zins K; Mogg M; Schneeberger C; Abraham D; Schreiber M
Int J Mol Sci; 2014 Jan; 15(1):712-24. PubMed ID: 24402127
[TBL] [Abstract][Full Text] [Related]
75. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife.
Kravitz HM; Janssen I; Lotrich FE; Kado DM; Bromberger JT
Am J Med; 2006 Sep; 119(9 Suppl 1):S87-93. PubMed ID: 16949393
[TBL] [Abstract][Full Text] [Related]
76. Aromatase (CYP19A1) gene variants, sex steroid levels, and late-life depression.
Ancelin ML; Norton J; Canonico M; Scarabin PY; Ritchie K; Ryan J
Depress Anxiety; 2020 Feb; 37(2):146-155. PubMed ID: 31730745
[TBL] [Abstract][Full Text] [Related]
77. Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.
Chen C; Sakoda LC; Doherty JA; Loomis MM; Fish S; Ray RM; Lin MG; Fan W; Zhao LP; Gao DL; Stalsberg H; Feng Z; Thomas DB
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3457-66. PubMed ID: 19064562
[TBL] [Abstract][Full Text] [Related]
78. Variation in the CYP19A1 gene and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Cancer Causes Control; 2011 Jul; 22(7):955-63. PubMed ID: 21479914
[TBL] [Abstract][Full Text] [Related]
79. Personalizing aromatase inhibitor therapy in patients with breast cancer.
Hamadeh IS; Patel JN; Rusin S; Tan AR
Cancer Treat Rev; 2018 Nov; 70():47-55. PubMed ID: 30086432
[TBL] [Abstract][Full Text] [Related]
80. Polymorphism 1558 C > T in the aromatase gene (CYP19A1) in low-grade endometrial stromal sarcoma.
Reich O; Regauer S; Tempfer C; Schneeberger C; Huber J
Eur J Gynaecol Oncol; 2011; 32(6):626-7. PubMed ID: 22335023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
